CytoDyn Inc (QB) (CYDY) 뉴스

tuesday is when it all changes...BIG TIME

I do love my long weekends especially this one... so many good things on the horizon for CytoDyn especially with the changes coming to our health care system.
So Univ of Missouri? Or Icahn School of Medicine?

I nominate Senator Rory Blunt for a Director's seat on the CytoDyn board. Maybe the Rory Blunt Lab will "show me" the state of affairs. Mizzou will help fund the fibrosis MASH study? Could be.

Seems to be a liking going on for Denmark and Novo Nordisk is on a buying tear. Eli Lily in hot pursuit. Other MASH players
jumping on the metabolic weight scale too. Will one give a wink to CytoDyn due to this weight loss fibrosis hunt? Let me say this,
sing it loud and sing it proud should we all of a sudden be in the big game. Stranger things have happened and we are certainly in strange times.

Don't give away the farm Dr. Jay.
$$$CYDY$$$ 2025

My God, a three year old can predict a penny stock fluctuating, you aren’t very smart is the reason nobody listens to you, nobody has sold a single share because of you, nobody, not one, very few people read charts FF

PSA:


All major U.S. stock markets will be closed on Monday January 20, in observance of Martin Luther King Jr. Day.

It was made up from the CEO and posters here. Don't understand how you now can't see that.
Aren't they back at Phase 1 of medical trials?
I'm only biased based on facts. The "bad actors" make money on each of the pumps....and dumps. All you need to know is how to read a stock chart, and observe the volume and trend in trading.
How many times do I need to predict accurately where the price will rise and fall to before people learn to listen?

I believe we have a good drug,but at this point,we need to have clinical trials to scientifically prove it.

Sorry when you make such a blanket statement such as "But none of it was true, was it?" I must completely disregard your posts.

There is significant CYDY news coming. Some might even be shocked.

How stupidly simplistic and wrong. Of course some of it was true. LL is a real drug with real results that thousands of people have taken. 

Anyone as biased as you should at least understand that bad actors often times effectively misuse truth. 

Your probably correct,but those were reasons it went up. Now we need a real trial with real results. Hopefully,they will design trial correctly

For those interested in reading posts from MGK_2:

https://www.reddit.com/r/Livimmune/comments/1i33nxw/games_people_play/

But none of it was true, was it?
Pumps and dumps abound.

There have been a few reasons stock has gone up. Investors believed that we were goint to get final ok for aids. Another time was covid trials ,and doctors who believed drug would work.

Based on your logic, why has the stock price EVER moved? The company has NEVER produced anything. So tell me, what could have possibly made the stock move in price over the years? I know you can get this one!

The Company will be prioritizing oncology in 2025, as we believe this indication holds the potential for the highest value return to the Company in the form of a significant partnership and/or drug approval. As recently announced, CytoDyn has received FDA clearance to initiate a Phase II study of leronlimab in patients with relapsed/refractory micro-satellite stable colorectal cancer (CRC). As noted in our prior release, we recently completed the kickoff meeting with Syneos Health, the CRO for the study, and enrollment efforts are set to begin in January. .............

......The second follow-up study involves the administration of CCL4, a drug that directly causes liver fibrosis in mice. This study will clarify if the observed reversal of liver fibrosis is restricted to the MASH/fat deposition pathway or might occur independently of the etiology of fibrosis (e.g. alcohol, viral hepatitis, etc.). The results from both follow-up studies will become available in January. As a side note, we have been contacted by colleagues at a major academic institution who indicated that, if the liver fibrosis reversal results are confirmed in the follow-up studies, they would be interested in funding a pilot study of leronlimab in the treatment of patients with pulmonary fibrosis at their own center.

Some have postulated that this second follow-up study may bring a very surprising update... maybe before month end????? OMG
$$$CYDY$$$ New collaborator coming?... maybe more!! Standing by for the rest of the story.

Hurry Pigeons... get me some more cheapies and step on it. Times a wasting. You sick birds are falling down on the job.

Of course, there are other things like buyout,but this stock has been in a small range for awhile. It will continue this range until news one way or another

10Q

https://www.cytodyn.com/investors/sec-filings/all-sec-filings/content/0001558370-25-000207/0001558370-25-000207.pdf

very simplistic viewpoint you promote. I can think of several reasons why the stock could move besides the initiaton of a human trial if that is what you mean.

Short or long there is no reason for stock to go up or down. If trials actually commence,then this would be a more optomisic time. If they dont start,this would create negativity.

MGK_2 is a case study in being always wrong, regarding his Cytodyn & Leronlimab analysis capabilities. A good example to (not) follow.

His past Reddit messages, all his messages, all demonstrate the same thing : his "sure things" never occur, and the contrary ends up crashing the company's stock price. Dozens of example. It's like watching a car crash rolling over repeatedly...he seems to have a knack for this. This poor MGK_2 thing, when will the suffering stop

Looks like the ShortyFlips have taken the off-ramp. Come on back pigeons, don't fly away on me now!!
All together now, give it your best shot. And hurry, money is burning a hole in my pocket.
Talk about more old Nada stuff or hammer on Tanya. Something effective must be in your bag of tricks somewhere.

Will we see a magical moment with Madrigal?

$$$CYDY$$$ 2025

From MGK_2:

https://www.reddit.com/r/Livimmune/comments/1i13186/off_ramp/

If you thought the stock was truly going up, it wouldn't matter. This still hasn't broken through resistance. Perhaps you don't believe it can.
Anyone who thinks this stock is going to rocket isn't worried about saving tenths of cents.
Are you sure you want to blame others? Your excuses appear quite lame

My God pigeons it's Monday, so do your job. How do you expect me to accumulate more shares with your pathetic excuses. Get to graveling!!
Time is running out.

Inching up on volume and pps. A bit higher on highs and higher lows as accumulation continues. And why not?
Nice strong close on Friday. The MM's are managing the pps to the upside now.

1 other thing (never discussed) is the damage done by allowing her to maintain weed/wine and his employment. Not to mention the disgust of putting him @ "president" and the millions wasted and time lost for shareholders so she could "reward" her friend with benefits

She got squeezed by Dr J as he made removal of her BFF condition of his position.

You gotta read all the filings. She has put in some very nicely arranged convertibles and preferred shares for David Welch's family.
The majority of shares are not with IHUB. they are held by insiders. The company must be arranged so that the voting rights stays with the insiders, and Tanya has experience in structuring a company. Tanya is doing a fine job for those she was hired to assist.
Some here think she cares about the share price, you're seeing it backwards. More important is the ability to give themselves shares. Dilution is not your friend, but it is for them.
BTW, there's a mole amongst you here. Look at the posters. One of these things is not like the others. The same poster who backed fully the other CEO up until the day he was prosecuted for fraud, is now trying to blame the mysterious shorts and posters here for the constant drop in share price.
The end of the year is for balancing books. IF, anyone here is short, they would have been covering at the end of the year, and thus making the share price rise momentarily. Don't be fooled by rhetoric. It's no different on this board than it is on any of the hundreds of other penny boards on IHUB.
P.S. The first resistance is at .153. Let's see if it can finish a week above it.
And look at the dates for the spikes, first of Jan, March, June, Sept.....almost as if its a pattern or something. Charting can be fun!

It takes a lot of effort and time to turn a company around. So far we seem to have climbed about 18% off the low in tax selling December. Not bad.

Shorts are running out of gas and out of things to talk about. So Tanya becomes the target however she has done ok so far in getting the ship headed north. The board members and advisory team no doubt have done what they were hired to do. I especially like the business leadership from Stephen Simes and Ryan Dunlap. For now we have the funds to take us through the foreseeable trials this year.

WE are advancing slow but certain with the pps yet to catch up to the fundamentals. As the company progresses with trials and studies being publicized, it should attract more investors making fund raising much easier. Remember however, Dr. Jay is working on collaborations and ways to fund future needs that are non-dilutive as outlined recently in the investors update. Funny though, how NP was a great money finder and the naysayers heaped on him for not being a
medical scientist. So now we need a business leader??? I'll take Dr. Jay and our Simes and Dunlap any day. Well, what will be the next pigeon invention? More leron saline? LMAO

Good Job Team CytoDyn. Keep it going slow and steady....not too fast with the updates please. Trying to add on the ever slowing dips. The enrollments should be getting along now. Guess we should hear something about that fairly soon. The accumulation going on is interesting.

SH's did vote her and everyone else back in recently. She did get fewer votes but I doubt she gave it much of a thought. Perhaps I'm wrong. The board members have a number of responsibilities although leading fundraising campains is probably not high on the list if at all. That would fall to CEO/CFO and perhaps Business Ops.

Yes the PPS sucks and that has happened during Tanya's and everybody elses tenure.

I don't know whether Tanya's relationship with Paulson hurts CYDY. I believe raising money via Fife and even private investors sucks at these PPS levels and needs to be replaced with better options by later this year.

What has tanya or any orher board membwr done to increase price of stock. Tanya and board haa let stock slip from over 1 to 12c. In my book that is horrible leadership. Maybe you like to lose a huge percentage of your investment but i dont. I think they have had some offers but didnt take them. Neyt time they have offer let shareholders vote on it.

What has tanya done. She has taken stock from over 1 to 12c. She has no clue what offers to accept. She is not money manager. She is front for paulson. What money has she raised?

Pretty sure all those investors are interested in a higher PPS. Tanya is/was put there to head up fixing CYDY's legal issues. Probably with a significant help from Paulson. Welch wants CYDY to succed more than anyone.

Having said that I don't disagree a money person would be a tremendous asset to CYDY. Whether that be a new COB or eventually as President/CEO might be up for debate.

In reality, you don't want a doctor as Chairman of the board, you want a money person. Ever see how a doctor manages money? This stock needs to raise money!
Now the downside, Tanya isn't there to help you, she's there to help David Welch and all the groups below:

Largest shareholders include Eagle Bay Advisors LLC, MAI Capital Management, Diversified Trust Co, Williams Jones Wealth Management, LLC., RFP Financial Group LLC, Next Capital Management LLC, Horizon Financial Services, Llc, Ancora Advisors, LLC, and Caz Investments Lp .

I recommend checking out some basics of any public company's website:

https://www.cytodyn.com/our-team/board-of-directors


https://www.cytodyn.com/our-team/scientific-advisory-board


https://www.cytodyn.com/our-team/leadership-team

Dr pestell fantastic addition,but he does not make decisions. Tanya and board does. They have no one on board including tanya that has scientific backround to make intelligent decisions about future.

Your posts always come off as a bit off base to me because you muddle pretty basic things and are contradictory. When you say "on board", do you mean literally on the board or involved? I ask because Jay isn't on the board of directors. But if you mean on board as in involved, then Jay is there and Pestell. Compounding my confusion about your posting is prior you complained often there was no cancer person. Is a cancer person not overlapping as a science person? I mean this is just the most obvious example, there are other “science” people. Do you see how convoluted you are being? Could you be more precise/transparent in your point/question?

Exactly,paulson keeps her there to aide them not common shareholder. If we had a scientic head, we would have much better chance. What company wants to talk to a paulson lawyer. I truely believe are drug works but other than jay no real science members on board. How can we expect any company to speak with us when we have only one science guy on board. Jay is good guy but he does not have the experience to navigate a good deal. Tanya has zero experience.

Yep it’s low quality PRs.

Pump, pump, pump !

It’s the 40th Cytodyn pump.

And every time it falls lower and lower.

MWA AH AH AH AH

Until Dr Lalezare explains why--AND FIXES
That cydy cannot sell shares ATM and can only do private placement--due to SEC ________________________???

Paulson et al will keep her in place or there will be no funding. IF anyone believes there is sufficient $$ in place to run 1 trial for 2 years (as stated @ clinical trials) plus overhead then good luck. Not to mention any other trial. So far there is no other funding. ALL those "partners" that were waiting for hold to be lifted. Partners waiting for samsung lawsuit. So far, same as s kelly lining up GSK partner in London--Dr D fantasy partners--weed/wine $$100 million amawrecks damages. All smoke (read lies)

Paulson makes money. The privvy guys get free warrants to minimize risks. The avg schlepp that buys retail shares get used and diluted.

Fix the SEC issues--kill 2 birds (or more) with 1 stone. Maximize funding. Minimize dilution. Protect retail. Get legit COB

Printing PR's off the company's website is not posting facts.
Now, if you have info from legit medical websites, that may be different. The company admittedly say they are years away. Why buy now?
Based on the charts, there were 4 different pump and dumps in 2024 alone. Are you holding long term or flipping?

I agree with most of what you say,but it hasnt transferred to stock going up. Tanya needs to be replaced with a science guy that is recognized in industry. Im shocked borad has let her run stock down from over dollar to 12c. Any other head would be let go. Plus her relationship with paulson is murky.

Personally I like the company now more than ever before. CEO Jay has done a remarkable job in everyone's view thus far. The FDA now has our back and not our ass in a ringer. Newbies that read the studies will learn of some great possibilities with leronlimab. It seems to be super safe too which has already been proven.
So as the future looks to reveal the attributes of leronlimab, I will be adding more and more. We have what appears to be a great future drug company in the making IMO, having weathered growing pains and obstacles... all man-made. Especially in two weeks with a changing of the guard at all levels of the health system, we should expect a good year to ensue as the trials move forward. $CYDY$

"The mechanism of action (“MOA”) of leronlimab has the potential to modulate the movement of T-cells to inflammatory sites, which could be beneficial by diminishing overactive inflammatory responses. Leronlimab is a unique humanized monoclonal antibody. Leronlimab binds to the second extracellular loop and N-terminus of the CCR5 receptor, and due to its selectivity and target-specific mechanism of action, it does not appear to activate the immune function of the CCR5 receptor through agonist activity. This apparent target specificity differentiates leronlimab from other CCR5 antagonists. Leronlimab is a competitive rather than allosteric inhibitor of the CCR5 receptor."

From MGK_2 at Reddit:

The GenoType of Leronlimab Leads to the PhenoType of the Leronlimab Disease Pattern

https://www.reddit.com/r/Livimmune/comments/1htj36s/the_genotype_of_leronlimab_leads_to_the_phenotype/

Yet I think any reasonable investor should be VERY careful to not confuse Cytodyn PRs with facts.

And be VERY careful with censorship. The Cytodyn pumpers on other message boards (hangout) censor pretty much anybody who disagrees with them or raises factual questions that put in doubt the -99% investment thesis (awesome performance by the way!).

A good investment starts with facts not being censored, whether they are good or bad, and I will be careful about that.

Some might even appreciate the opportunity presented in part due to NP's behavior.

That is some MAJOR spin right there

Facts are facts and shouldn't be hidden--ODD you like Livimmune etc where they post NOT FACTS about Tony C being the CEO and Dr Pestell being the CEO --THEN when someone points out the LIEs --you and wax et al want the person posting FACT banned

So you promote Livimmune which supports LIEs and fantasy and bans honest posts--yet HERE you state FACTS should NOT be hidden

Hard to keep it all straight

Hopefully the plan is not to turn this board into Livimmune or Inv Hang with those frauds

Facts are facts and shouldn't be hidden. Some might even appreciate the opportunity presented in part due to NP's behavior. You can "warn any newbies" all you want but I think new investors will be much more interested in current events moving forward.

https://www.cytodyn.com/newsroom/press-releases/detail/633/december-2024-letter-to-shareholders

First off, its pretty well known Charlie Sheen left 2 1/2 Men left right before the royalties kick in, and that's why Ashton Kutcher took the job( I happen to know one of the writers). ,but nonetheless..
what I don't understand is how you can have a stock board where you can make any erroneous claim anyone wishes as long as its positive, and it is acceptable. However, if you state anything negative, even with facts, you have to justify your being there.
Personally, I have no problem with you being here and/or losing your money. My goal is to warn any newbies that not everyone here is being honest and they should have both sides of the story. You see, while you may have blue chip stocks, I doubt most on IHUB do and many here are naive.
Don't you feel its important that any newbie know the last CEO was found guilty of fraud, and some of the posters here have vouched for him?

Like it or not Charlie used leronlimab with great success.
As far as celebrities go, Charlie has a incredible career. I'd be thrilled to have the royalty payments alone.

At these prices you are paying for what you have gotten. No argument there. Of course that isn't the point. Stocks are purchased with the expectation of price appreciation in the future. I have a bunch of blue chip dividend paying stocks. If I or anyone else wants to buy a 12 cent speculative stock that may take time to bear fruit or not , why should anyone have a problem with them doing so.

Wasn't he also taking tiger's blood?
Very relevant comment that illustrates the poor judgment capabilities of Charlie, who was a promoter of Leronlimab…

…yes this trash stock has attracted trash celebrities….not a surprise then that this stock has failed every rendez-vous with its investors…you get what you pay for…

Wasn't he also taking tiger's blood?

That's huge ... And I apologize I saw a small clip of him talking about it, and I thought it was more recent than it was